Portage Biotech

PRTG49

Penny Stock

$4.09arrow_drop_up3.03%$0.12

Penny Stock

PRTG49

$4.09

arrow_drop_up3.03%$0.12

Penny Stock

Performance History

Key Stats
Open	$4.17
Prev. Close	$3.95
EPS	24.40
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$4.28M

	LOW	HIGH
Day Range	3.95	4.17
52 Week Range	2.10	58.60

Ratios

Revenue	-



EBITDA Margin %	-

EPS	24.40

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Portage Biotech (PRTG)

Portage Biotech Inc. (NASDAQ: PRTG) is a biotechnology company focused on the discovery and development of innovative therapies for the treatment of cancer and other diseases. With a strong pipeline of potential drug candidates, Portage Biotech is poised to make a significant impact in the medical field. The company's mission is to improve the lives of patients by advancing cutting-edge science and technology. Through strategic partnerships and collaborations, Portage Biotech is able to accelerate the development of its promising drug candidates. With a market cap of over $500 million, Portage Biotech is well-positioned for growth in the biotechnology sector.

Portage Biotech's stock price history has shown strong performance over the past year. Despite the volatility of the overall market, PRTG has consistently outperformed its peers. This can be attributed to the company's strong research and development efforts, as well as its ability to attract top talent in the industry. Investors have recognized the potential of Portage Biotech's drug candidates and have shown confidence in the company's ability to bring them to market. As a result, PRTG stock has seen significant gains and has outpaced the broader market.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Ian B. Walters M.B.A., M.D.
Headquarters: Tortola
Employees: 7
Exchange: NASDAQ

Keep an eye on Portage Biotech

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Portage Biotech's (PRTG) price per share?

The current price per share for Portage Biotech (PRTG) is $4.09. The stock has seen a price change of $0.12 recently, indicating a 3.04% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Portage Biotech (PRTG)?

For Portage Biotech (PRTG), the 52-week high is $58.6, which is 1.33K% from the current price. The 52-week low is $2.1, the current price is 94.76% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Portage Biotech (PRTG) a growth stock?

Portage Biotech (PRTG) has shown an average price growth of -6.65% over the past three years. It has received a score of 63 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Portage Biotech as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Portage Biotech (PRTG) stock price performance year to date (YTD)?

As of the latest data, Portage Biotech (PRTG) has a year-to-date price change of -89.18%. Over the past month, the stock has experienced a price change of -38.96%. Over the last three months, the change has been 48.73%. Over the past six months, the figure is -23.41%.

help

Is Portage Biotech (PRTG) a profitable company?

Portage Biotech (PRTG) has a net income of -$75.34M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$18.25M. Furthermore, the EBITDA is -$16.04M.

help

What is the market capitalization of Portage Biotech (PRTG)?

Portage Biotech (PRTG) has a market capitalization of $4.29M. The average daily trading volume is 4.09, indicating the stock's liquidity and investor engagement.